Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, produ…
Emergent BioSolutions Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
EBS-DEBT-9208
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
EBS-DEBT
Debt stack $584.6M
90%
Market cache reports total debt of $584.6M.
EBS-DEBT-9207
Warrants outstanding: 5500000
90%
xbrl warrant detail from xbrl 2025-12-31.
Emergent BioSolutions Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Emergent BioSolutions Inc..
Emergent BioSolutions Inc. Ownership
Holder
Name
Confidence
Evidence
EBS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 192 tracked holders.
Emergent BioSolutions Inc. Extended Supply Chain Network